Overview
Interest is growing for natural killer T cell (NK cell)-based therapies for treating various diseases, including cancer and infectious diseases. NK cells have their ability to recognize and kill abnormal cells without prior sensitization, and the potential to enhance the efficacy of existing therapies. Download this industry analysis to learn about how to create a cost-effective NK cell program.
